Immune adherence-mediated opsonophagocytosis: The mechanism of Leishmania infection

Journal of Experimental Medicine

Volumn 189, Issue 1, 1999, Pages 25-35

  Domínguez, Mercedes ^a   Toraño, Alfredo ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Complement; Immune adherence; Infection; Leishmania; Natural antibodies

Indexed keywords

ANTIBODY; COMPLEMENT COMPONENT C3; RECEPTOR;

AMASTIGOTE; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; ERYTHROCYTE; HUMAN; HUMAN CELL; IMMUNE ADHERENCE; LEISHMANIA; LEISHMANIASIS; LEUKOCYTE; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROMASTIGOTE;

ANIMALS; ANTIBODIES; CELL SURVIVAL; COMPLEMENT SYSTEM PROTEINS; ERYTHROCYTES; HUMANS; IMMUNE ADHERENCE REACTION; KINETICS; LEISHMANIA DONOVANI; LEISHMANIASIS; LEUKOCYTES; OPSONIN PROTEINS; PHAGOCYTOSIS; VACCINATION;

EID: 0344959468     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.1.25     Document Type: Article

References (60)

1. Ribeiro, J.M.C. 1995. Blood-feeding arthropods: live syringes or invertebrate pharmacologists? Infect. Agents Dis. 4:143-152.
2. Mosser, D.M., and L.A. Rosenthal. 1993. Leishmania-macrophage interactions: multiple receptors, multiple ligands and diverse cellular responses. Semin. Cell Biol. 4:315-322.
3. Brittingham, A., and D.M. Mosser. 1996. Exploitation of the complement system by Leishmania promastigotes. Parasitol. Today. 12:444-447.
4. Wright, S.D., and S.C. Silverstein. 1983. Receptors for C3b and C3bi promote phagocytosis but not the release of toxic oxygen from human phagocytes. J. Exp. Med. 158:2016-2023.
5. Hill, J.O. 1986. Pathophysiology of experimental leishmaniasis: pattern of development of metastatic disease in the susceptible host. Infect. Immun. 52:364-369.
6. Chang, K.-P. 1979. Leishmania donovani: promastigote-macrophage surface interactions in vitro. Exp. Parasitol. 48:175-189.
7. Pearson, R.D., R. Romito, P.H. Symes, and J.L. Harcus. 1981. Interaction of Leishmania donovani promastigotes with human monocyte-derived macrophages: parasite entry, intracellular survival, and multiplication. Infect. Immun. 32:1249-1253.
8. Klempner, M.S., M. Cendron, and D.J. Wyler. 1983. Attachment of plasma membrane vesicles of human macrophages to Leishmania tropica promastigotes. J. Infect. Dis. 148: 377-384.
9. Locksley, R.M., F.P. Heinzel, J.E. Frankhauser, C.S. Nelson, and M.D. Sadick. 1988. Cutaneous host defense in leishmaniasis: interaction of isolated dermal macrophages and epidermal Langerhans cells with the insect-stage promastigote. Infect. Immun. 56:336-342.
10. Pearson, R.D., and R.T. Steigbigel. 1981. Phagocytosis and killing of the protozoan Leishmania donovani by human polymorphonuclear leukocytes. J. Immunol. 127:1438-1443.
11. Axelrod, O., S. Klaus, and S. Frankenburg. 1994. Antigen presentation by epidermal Langerhans cells in experimental cutaneous leishmaniasis. Parasite Immunol. 16:593-598.
12. Ridley, M.J., and C.W. Wells. 1986. Macrophage-parasite interaction in the lesions of cutaneous leishmaniasis. An ultrastructural study. Am. J. Pathol. 123:79-85.
13. Williams, R.O. 1988. Invasion of murine dendritic cells by Leishmania major and Leishmania mexicana. J. Parasitol. 74: 186-187.
14. Lewis, D.H. 1974. Infection of tissue culture cells of low phagocytic ability by Leishmania mexicana mexicana. Ann. Trop. Med. Parasitol. 68:327-336.
15. Schwartzman, J.D., and R.D. Pearson. 1985. The interaction of Leishmania donovani promastigotes and human fibroblasts in vitro. Am. J. Trop. Med. Hyg. 34:850-855.
16. Rey, H. 1943. Cellular reactions in the dermal connective tissue of the hamster to Leishmania brasiliensis. J. Infect. Dis. 72:117-124.
17. Wilson, M.E., D.J. Innes, A. Sousa, and R.D. Pearson. 1987. Early histopathology of experimental infection with Leishmania donovani in hamsters. J. Parasitol. 73:55-63.
18. Pompeu, M.L., L.A. Freitas, M.L.V. Santos, M. Khouri, and M. Barral-Netto. 1991. Granulocytes in the inflammatory process of BALB/c mice infected by Leishmania amazonensis. A quantitative approach. Acta Trop. 48:185-193.
19. Beil, W.J., G. Meinardus-Hager, D.-C. Neugebauer, and C. Sorg. 1992. Differences in the onset of the inflammatory response to cutaneous leishmaniasis in resistant and susceptible mice. J. Leukoc. Biol. 52:135-142.
20. Chang, K.-P., and L.D. Hendricks. 1985. Laboratory cultivation and maintenance of Leishmania. In Leishmaniasis. K.-P. Chang and R.S. Bray, editors. Elsevier, Amsterdam. 1-30.
21. Metcalf, J.A., J.I. Gallin, W.M. Nauseef, and R.K. Root. 1986. Neutrophil purification. In Laboratory Manual of Neutrophil Function. J.A. Metcalf, J.I. Gallin, W.M. Nauseef, and R.K. Root, editors. Raven Press, New York. 2-6.
22. Esparza, I., R.I. Fox, and R.D. Schreiber. 1986. Interferon-γ-dependent modulation of C3b receptors (CR1) on human peripheral blood monocytes. J. Immunol. 136:1360-1365.
23. O'Shea, J.J., E.J. Brown, B.E. Seligmann, J.A. Metcalf, M.M. Frank, and J.I. Gallin. 1985. Evidence for distinct intracellular pools of receptors for C3b and C3bi in human neutrophils. J. Immunol. 134:2580-2587.
24. Cook, J., E. Fischer, C. Boucheix, M. Mirsrahi, M.-H. Jouvin, L. Weiss, M.R. Jack, and M.D. Kazatchkine. 1985. Mouse monoclonal antibodies to the human C3b receptor. Mol. Immunol. 22:531-539.
25. Mason, D.W., and A.F. Williams. 1980. The kinetics of antibody binding to membrane antigens in solution and at the cell surface. Biochem. J. 187:1-20.
26. Fine, D.P., S.R. Marney, Jr., D.G. Colley, J.S. Sergent, and R.M. Des Prez. 1972. C3 shunt activation in human serum chelated with EGTA. J. Immunol. 109:807-809.
27. Eisenthal, R., and A. Cornish-Bowden. 1974. The direct linear plot. A new graphical procedure for estimating enzyme kinetic parameters. Biochem. J. 139:715-720.
28. Hostetter, M.K., R.A. Krueger, and D.J. Schmeling. 1984. The biochemistry of opsonization: central role of the reactive thiolester of the third component of complement. J. Infect. Dis. 150:653-661.
29. Ezzell, J.L., L.A. Wilcox, N.J. Bernshaw, and C.J. Parker. 1991. Induction of the paroxysmal nocturnal hemoglobinuria phenotype in normal human erythrocytes: effects of 2-aminoethylisothiouronium bromide on membrane proteins that regulate complement. Blood. 77:2764-2773.
30. Dorval, B.L., F.G. Cosio, D.J. Birmingham, and L.A. Hebert. 1989. Human erythrocytes inhibit complement-mediated solubilization of immune complexes. J. Immunol. 142: 2721-2727.
31. Mosser, D.M., and P.J. Edelson. 1987. The third component of complement (C3) is responsible for the intracellular survival of Leishmania major. Nature. 327:329-331.
32. Nickells, M., R. Hauhart, M. Krych, V. Bala Subramanian, K. Geoghegan-Barek, H.C. Marsh, Jr., and J.P. Atkinson. 1998. Mapping epitopes for 20 monoclonal antibodies to CR1. Clin. Exp. Immunol. 112:27-33.
33. Emlen, W., G. Burdick, V. Carl, and P.J. Lachmann. 1989. Binding of model immune complexes to erythrocyte CR1 facilitates immune complex uptake by U937 cells. J. Immunol. 142:4366-4371.
34. Avrameas, S., and T. Ternynck. 1995. Natural autoantibodies: the other side of the immune system. Res. Immunol. 146: 235-248.
35. Bachmann, M.F., U. Kalinke, A. Althage, G. Freer, C. Burkhart, H.-P. Roost, M. Aguet, H. Hengartner, and R.M. Zinkernagel. 1997. The role of antibody concentration and avidity in antiviral protection. Science. 276:2024-2027.
36. Ulrich, M., D. Trujillo Ortiz, and J. Convit. 1968. The effect of fresh serum on the leptomonads of Leishmania. I. Preliminary report. Trans. R. Soc. Trop. Med. Hyg. 62:825-830.
37. Schmunis, G.A., and R. Herman. 1970. Characteristics of socalled natural antibodies in various normal sera against culture forms of Leishmania. J. Parasitol. 56:889-896.
38. Pearson, R.D., and R.T. Steigbigel. 1980. Mechanism of lethal effect of human serum upon Leishmania donovani. J. Immunol. 125:2195-2201.
39. Mosser, D.M., S.K. Burke, E.E. Coutavas, J.F. Wedgwood, and P.J. Edelson. 1986. Leishmania species: mechanisms of complement activation by five strains of promastigotes. Exp. Parasitol. 62:394-404.
40. Avila, J.L., M. Rojas, and U. Galili. 1989. Immunogenic Galα1→3Gal carbohydrate epitopes are present on pathogenic American Trypanosoma and Leishmania. J. Immunol. 142:2828-2834.
41. Navin, T.R., E.C. Krug, and R.D. Pearson. 1989. Effect of immunoglobulin M from normal human serum on Leishmania donovani promastigote agglutination, complement-mediated killing, and phagocytosis by human monocytes. Infect. Immun. 57:1343-1346.
42. Puentes, S.M., D.L. Sacks, R.P. Da Silva, and K.A. Joiner. 1988. Complement binding by two developmental stages of Leishmania major promastigotes varying in expression of a surface lipophosphoglycan. J. Exp. Med. 167:887-902.
43. Mosser, D.M., and P.J. Edelson. 1984. Activation of the alternative complement pathway by Leishmania promastigotes: parasite lysis and attachment to macrophages. J. Immunol. 132:1501-1505.
44. Puentes, S.M., D.M. Dwyer, P.A. Bates, and K.A. Joiner. 1989. Binding and release of C3 from Leishmania donovani promastigotes during incubation in normal human serum. J. Immunol. 143:3743-3749.
45. Ofek, I., J. Goldhar, Y. Keisari, and N. Sharon. 1995. Nonopsonic phagocytosis of microorganisms. Ann. Rev. Microbiol. 49:239-276.
46. Medof, M.E., G.M. Prince, and J.J.-F. Oger. 1982. Kinetics of interaction of immune complexes with complement receptors on human blood cells: modification of complexes during interaction with red cells. Clin. Exp. Immunol. 48: 715-725.
47. Edberg, J.C., E. Wright, and R.P. Taylor. 1987. Quantitative analyses of the binding of soluble complement-fixing antibody/dsDNA immune complexes to CR1 on human red blood cells. J. Immunol. 139:3739-3747.
48. Rowe, J.A., J.M. Moulds, C.I. Newbold, and L.H. Miller. 1997. P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature. 388:292-295.
49. Wallace, J.M., and A. Wormall. 1931. Red-cell adhesion in trypanosomiasis of man and other animals. II. Some experiments on the mechanism of the reaction. Parasitology. 23: 346-359.
50. Da Silva, R.P., B. Fenton Hall, K.A. Joiner, and D.L. Sacks. 1989. CR1, the C3b receptor, mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages. J. Immunol. 143:617-622.
51. Rosenthal, L.A., F.S. Sutterwala, M.E. Kehrli, and D.M. Mosser. 1996. Leishmania major-human macrophage interactions: cooperation between Mac-1 (CD11b/CD18) and complement receptor type 1 (CD35) in promastigote adhesion. Infect. Immun. 64:2206-2215.
52. Brittingham, A., C.J. Morrison, W.R. McMaster, B.S. McGwire, K.-P. Chang, and D.M. Mosser. 1995. Role of the Leishmania surface protease gp63 in complement fixation, cell adhesion, and resistance to complement-mediated lysis. J. Immunol. 155:3102-3111.
53. Sutterwala, F.S., L.A. Rosenthal, and D.M. Mosser. 1996. Cooperation between CR1 (CD35) and CR3 (CD11b/ CD18) in the binding of complement-opsonized particles. J. Leukoc. Biol. 59:883-890.
54. Nielsen, C.H., S.H. Matthiesen, I. Lyng, and G.Q. Leslie. 1997. The role of complement receptor type 1 (CR1, CD35) in determining the cellular distribution of opsonized immune complexes between whole blood cells: kinetic analysis of the buffering capacity of erythrocytes. Immunology. 90:129-137.
55. Chang, K.-P. 1981. Leishmanicidal mechanisms of human polymorphonuclear phagocytes. Am. J. Trop. Med. Hyg. 30: 322-333.
56. Mirkovich, A.M., A. Galelli, A.C. Allison, and F.Z. Modabber. 1986. Increased myelopoiesis during Leishmania major infection in mice: generation of "safe targets", a possible way to evade the effector immune mechanism. Clin. Exp. Immunol. 64:1-7.
57. Nelson, D.S. 1963. Immune adherence. Adv. Immunol. 3:131-180.
58. Arnaout, M.A., N. Dana, J. Melamed, R. Medicus, and H.R. Colten. 1983. Low ionic strength or chemical crosslinking of monomeric C3b increases its binding affinity to the human complement C3b receptor. Immunology. 48:229-237.
59. Cooper, N.R. 1969. Immune adherence by the fourth component of complement. Science. 165:396-398.
60. Modabber, F. 1996. Vaccine: the only hope to control Leishmaniasis. In Molecular and Immune Mechanisms in the Pathogenesis of Cutaneous Leishmaniasis. F.J. Tapia, G. Cáceres-Dittmar, and M.A. Sánchez, editors. R.G. Landes Company, Austin, TX. 223-236.